Canine DCM has been a hot pet food topic for the past year. Let’s look deeper into the latest FDA investigation update and if veterinary bias may play a role.

Canine dilated cardiomyopathy (DCM) is a hot topic in the pet food industry, veterinary community, press and among pet owners. The cause of recent cases is unknown.

The Pet Nutrition Alliance claims to provide resources to vets, but the pet food company information is incomplete and flawed, and no sponsors are disclosed.

Petco has been receptive to feedback but is still light years away from their “turning our backs on artificial ingredients in pet foods” promise.

The reality is that Petco, claiming to be the first and only major pet food retailer to make this move, has not banned all artificial ingredients.

Pet owners can report adverse pet food events directly to regulatory agencies, and it’s important for pet food companies to know the process, too.

Are pet food consumer advocates really looking out for the best interests of pet owners and their pets, or are they simply fearmongers in disguise?

Transparency shouldn’t be used merely as a pet food buzzword and should have some teeth behind its meaning. Pet owners want the facts as they stand today.

Do AAFCO feeding trials matter for pet food nutrition? Before we answer that question, let’s dive into some packaging claims.

Depending on which US state you manufacture your pet food in, it may be difficult or impossible to meet guidelines for human grade pet food claims.